# Ascend Gene & Cell Therapies funding: rounds and investors

> Ascend Gene & Cell Therapies has raised $66M across 1 round since 2023. Investors include DCVC, LD Capital and Deerfield. Every round with its source.

Source: https://millionrounds.com/company/ascend-gene-and-cell-therapies (Millionrounds; every figure on the page links to its filing or article)

United Kingdom · [Series A startup](https://millionrounds.com/companies)

# Who invested in *Ascend Gene & Cell Therapies*

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summary Updated 26 Oct 2026

**$66M** raised across 1 round since 2023, from 2 sources

- **Latest round:** Series A, $66M Mar 2023
- **Investors:** 4

See who backed them

## The rounds

- **Mar 2023** Series A **$66M** [DCVC](https://millionrounds.com/fund/data-collective) [LD Capital](https://millionrounds.com/fund/xie) [Deerfield](https://millionrounds.com/fund/deerfield) [Digitalis Ventures](https://millionrounds.com/fund/digitalis-ventures) Source recorded and 1 other SEC filing: $67M sold, first sale Feb 2023

## Everyone who backed them

[DCVC](https://millionrounds.com/fund/data-collective) VC firm **1** round

[LD Capital](https://millionrounds.com/fund/xie) VC firm **1** round

[Deerfield](https://millionrounds.com/fund/deerfield) VC firm **1** round

[Digitalis Ventures](https://millionrounds.com/fund/digitalis-ventures) VC firm **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=ascend-gene-and-cell-therapies).

## Quick answers about Ascend Gene & Cell Therapies

### Who invested in Ascend Gene & Cell Therapies?

Ascend Gene & Cell Therapies's investors include DCVC, LD Capital, Deerfield and Digitalis Ventures.

### How much has Ascend Gene & Cell Therapies raised?

Ascend Gene & Cell Therapies has raised $66M across 1 round since 2023.

### When did Ascend Gene & Cell Therapies last raise?

Ascend Gene & Cell Therapies's most recent round was a Series A of $66M in Mar 2023.

### What was Ascend Gene & Cell Therapies's biggest round?

Its most recent round, $66M in Mar 2023, is also its largest on record.

### Who backed Ascend Gene & Cell Therapies first?

Ascend Gene & Cell Therapies's first round on record, in Mar 2023, was backed by DCVC, LD Capital and Deerfield and 1 others.

### What stage is Ascend Gene & Cell Therapies at?

Ascend Gene & Cell Therapies's latest named round is a Series A, in Mar 2023.

### Where is Ascend Gene & Cell Therapies based?

Ascend Gene & Cell Therapies is based in the United Kingdom.

## Companies like Ascend Gene & Cell Therapies

In the same sector, and raised in the last eighteen months.

[**HydRegen** $12M · Oct 2026](https://millionrounds.com/company/hydregen)[**OMass Therapeutics** $442M · Oct 2026](https://millionrounds.com/company/omass-therapeutics)[**CMR Surgical** $1.1B · Oct 2026](https://millionrounds.com/company/cmr-surgical)[**Living Optics** $61M · Oct 2026](https://millionrounds.com/company/living-optics)[**Bactobio** $18M · Oct 2026](https://millionrounds.com/company/bactobio)[**RHYTHM AI** $23M · Sept 2026](https://millionrounds.com/company/rhythm-ai)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app